Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20226 (
TATA-binding protein
)
1,297
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Spinocerebellar ataxia type 7 (SCA7) is a neurodegenerative disorder caused by a CAG repeat expansion in the SCA7 gene leading to elongation of a polyglutamine tract in
ataxin-7
, a protein of unknown function. A putative
ataxin-7
yeast orthologue (SGF73) has been identified recently as a new component of the SAGA (Spt/Ada/Gcn5 acetylase) multisubunit complex, a coactivator required for transcription of a subset of RNA polymerase II-dependent genes. We show here that
ataxin-7
is an integral component of the mammalian SAGA-like complexes, the
TATA-binding protein
-free TAF-containing complex (TFTC) and the SPT3/TAF9/GCN5 acetyltransferase complex (STAGA). In agreement, immunoprecipitation of
ataxin-7
retained a histone acetyltransferase activity, characteristic for TFTC-like complexes. We further identified a minimal domain in
ataxin-7
that is required for interaction with TFTC/STAGA subunits and is conserved highly through evolution, allowing the identification of a SCA7 gene family. We showed that this domain contains a conserved Cys(3)His motif that binds zinc, forming a new zinc-binding domain. Finally, polyglutamine expansion in
ataxin-7
did not affect its incorporation into TFTC/STAGA complexes purified from SCA7 patient cells. We demonstrate here that
ataxin-7
is the human orthologue of the yeast SAGA SGF73 subunit and is a bona fide subunit of the human TFTC-like transcriptional complexes.
...
PMID:Ataxin-7 is a subunit of GCN5 histone acetyltransferase-containing complexes. 1511 62
SCA7 (spinocerebellar ataxia type 7) is a neurodegenerative disorder caused by a CAG repeat expansion in the SCA7 gene that leads to elongation of a polyglutamine tract in
ataxin-7
, a protein of unknown function. Sgf73, a putative yeast orthologue of
ataxin-7
, has been identified as a new component of the yeast SAGA (Spt/Ada/Gcn5 acetyltransferase) multisubunit complex, a co-activator required for the transcription of a subset of RNA polymerase II-dependent genes. We show here that
ataxin-7
is an integral component of mammalian SAGA-like complexes, i.e. the TFTC [TBP (
TATA-binding protein
)-free TAF (TBP-associated factor) complex] and the STAGA (SPT3/TAF9/GCN5 acetyltransferase) complex. In agreement with this, immunoprecipitation of
ataxin-7
retained a histone acetyltransferase activity characteristic of TFTC-like complexes. Moreover, polyglutamine expansion in
ataxin-7
did not affect its incorporation into TFTCs/STAGA complexes purified from cells from a SCA7 patient. We demonstrate here that
ataxin-7
is the human orthologue of a the yeast SAGA Sgf73 subunit, and is a bona fide subunit of human TFTC-like transcriptional complexes.
...
PMID:Both normal and polyglutamine- expanded ataxin-7 are components of TFTC-type GCN5 histone acetyltransferase- containing complexes. 1662 96
The spinocerebellar ataxia type 7 (SCA7) gene product,
Ataxin-7
(
ATXN7
), localizes to the nucleus and has been shown to function as a component of the
TATA-binding protein
-free TAF-containing-SPT3-TAF9-GCN5-acetyltransferase transcription complex, although cytoplasmic localization of
ATXN7
in affected neurons of human SCA7 patients has also been detected. Here, we define a physiological function for cytoplasmic
ATXN7
. Live imaging reveals that the intracellular distribution of
ATXN7
dynamically changes and that
ATXN7
distribution frequently shifts from the nucleus to the cytoplasm. Immunocytochemistry and immunoprecipitation demonstrate that cytoplasmic
ATXN7
associates with microtubules (MTs), and expression of
ATXN7
stabilizes MTs against nocodazole treatment, while
ATXN7
knockdown enhances MT degradation. Interestingly, normal and mutant
ATXN7
similarly associate with and equally stabilize MTs. Taken together, these findings provide a novel physiological function of
ATXN7
in the regulation of cytoskeletal dynamics, and suggest that abnormal cytoskeletal regulation may contribute to SCA7 disease pathology.
...
PMID:Ataxin-7 associates with microtubules and stabilizes the cytoskeletal network. 2210 Jul 62